Current Treatments for Diabetic Macular Edema

Area of Science:

• Ophthalmology
• Diabetology
• Neuroscience

Background:

• Diabetic retinopathy is a leading cause of blindness.
• Diabetic macular edema (DME) significantly impairs vision in diabetic patients.
• DME involves retinal capillary obstructions, vascular damage, and hyperpermeability driven by VEGF.

Purpose of the Study:

• To review effective treatments for diabetic macular edema.
• To highlight the neuroprotective benefits of timely DME intervention.
• To emphasize maintaining vision quality by preventing neural cell damage.

Main Methods:

• Review of current literature on diabetic macular edema treatments.
• Analysis of the pathophysiology of DME and its impact on neurovascular units (NVUs).
• Discussion of optical coherence tomography (OCT) in monitoring DME and NVU status.

Main Results:

• DME leads to hemorrhages, leakage, and NVU failure.
• Persistent edema causes neural cell damage, resulting in diabetic neuropathy and vision loss.
• Neuronal cell death and axonal degeneration are irreversible consequences of untreated DME.

Conclusions:

• Timely treatment of DME is essential for neuroprotection.
• Intervention before OCT-detectable neural changes can prevent permanent visual loss.
• Effective DME treatments offer neuroprotective benefits, maintaining good vision.